You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2025

List of Excipients in API METYROSINE


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing METYROSINE

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Bausch Health US LLC DEMSER metyrosine 25010-305 FD&C BLUE NO. 2
Bausch Health US LLC DEMSER metyrosine 25010-305 GELATIN
Bausch Health US LLC DEMSER metyrosine 25010-305 HYDROXYPROPYL CELLULOSE
Bausch Health US LLC DEMSER metyrosine 25010-305 MAGNESIUM STEARATE
Bausch Health US LLC DEMSER metyrosine 25010-305 SILICON DIOXIDE
Bausch Health US LLC DEMSER metyrosine 25010-305 TITANIUM DIOXIDE
Oceanside Pharmaceuticals METYROSINE metyrosine 68682-310 FD&C BLUE NO. 2
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Get Started Free

Excipients in ANDA-approved (generic) drugs containing METYROSINE

Company Ingredient NDC Excipient
Amneal Pharmaceuticals NY LLC metyrosine 60219-1621 ALCOHOL
Amneal Pharmaceuticals NY LLC metyrosine 60219-1621 AMMONIA
Amneal Pharmaceuticals NY LLC metyrosine 60219-1621 BUTYL ALCOHOL
Amneal Pharmaceuticals NY LLC metyrosine 60219-1621 D&C YELLOW NO. 10
Amneal Pharmaceuticals NY LLC metyrosine 60219-1621 FD&C BLUE NO. 1
Amneal Pharmaceuticals NY LLC metyrosine 60219-1621 FD&C RED NO. 3
Amneal Pharmaceuticals NY LLC metyrosine 60219-1621 FD&C RED NO. 40
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Get Started Free

Detailed excipient profiles for METYROSINE

Excipient focus: ALCOHOL

Excipient focus: AMMONIA

Excipient focus: BUTYL ALCOHOL

Excipient focus: D&C YELLOW NO. 10

Excipient focus: FD&C BLUE NO. 1

Excipient focus: FD&C BLUE NO. 2

Excipient focus: FD&C RED NO. 3

Excipient focus: FD&C RED NO. 40

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: GELATIN

Excipient focus: HYDROXYPROPYL CELLULOSE

Excipient focus: HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED

Excipient focus: ISOPROPYL ALCOHOL

Excipient focus: LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: POTASSIUM HYDROXIDE

Excipient focus: PROPYLENE GLYCOL

Excipient focus: SHELLAC

Excipient focus: SILICON DIOXIDE

Excipient focus: TITANIUM DIOXIDE

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links